News & Updates

BMI and glycaemic status significantly affect CV risk in patients treated with anthracyclines

24 Jun 2025 by

A retrospective cohort study of >11,000 Hong Kong patients who initiated anthracycline-based chemotherapy found that both body-mass index (BMI) and glycaemic status significantly affect cardiovascular (CV) risks, with the highest risk observed in those with concurrent obesity and diabetes/prediabetes.

BMI and glycaemic status significantly affect CV risk in patients treated with anthracyclines

24 Jun 2025

Long-term data solidify partial-breast RT as standard of care in low-risk early breast cancer

23 Jun 2025 by

In patients with low-risk, early-stage breast cancer who have undergone breast-conserving surgery, partial-breast radiotherapy (RT) is as safe and efficacious as whole-breast RT, according to 10-year data from the phase III IMPORT LOW trial.

Long-term data solidify partial-breast RT as standard of care in low-risk early breast cancer

23 Jun 2025

Carvedilol trumps propranolol in preventing decompensation in cirrhosis

23 Jun 2025

A recent study has provided data bolstering the current recommendation of using carvedilol to prevent a first decompensation of cirrhosis in patients with compensated cirrhosis.

Carvedilol trumps propranolol in preventing decompensation in cirrhosis

23 Jun 2025

Penpulimab extends survival in R/M nasopharyngeal carcinoma

23 Jun 2025 by

The use of penpulimab, in combination with gemcitabine and cisplatin or carboplatin, as first-line treatment for recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC) provides statistically significant and clinically meaningful benefit, according to a study presented at AACR 2025.

Penpulimab extends survival in R/M nasopharyngeal carcinoma

23 Jun 2025

Metabolic burden ups risk of death in CHB patients with SLD

23 Jun 2025

Metabolic burden in patients with chronic hepatitis B (CHB) and concurrent steatotic liver disease (SLD) may exacerbate the risks of all-cause, liver-related, and cardiovascular mortality, suggests a study.

Metabolic burden ups risk of death in CHB patients with SLD

23 Jun 2025

IgAN drug hits target in phase III study

23 Jun 2025 by

The selective immunoglobulin (Ig)G2 antibody sibeprenlimab reduces proteinuria in individuals with IgA nephropathy (IgAN) in an interim analysis of the phase III VISIONARY study.

IgAN drug hits target in phase III study

23 Jun 2025

Paternal mental distress may affect child development

23 Jun 2025

The perinatal mental distress experienced by a father appears to have a negative effect on the offspring’s developmental outcomes from infancy through adolescence, according to a meta-analysis.

Paternal mental distress may affect child development

23 Jun 2025

Original New Drug Application Approvals by US FDA (16-31 May 2025)

23 Jun 2025

New drug applications approved by US FDA as of 16-31 May 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 May 2025)

23 Jun 2025

Wearable electroencephalograph device useful for detecting absence seizures

22 Jun 2025 by

A wearable electroencephalograph (EEG) device that leverages artificial intelligence allows for precise, 12-to-24-h home monitoring of absence seizures, enabling rapid and tailored adjustments to antiseizure medication (ASM) and eliminating the need for further hospital admissions, as shown in an exploratory study.

Wearable electroencephalograph device useful for detecting absence seizures

22 Jun 2025

Limited health literacy in CKD patients tied to poor self-care

22 Jun 2025 by

Some patients with chronic kidney disease (CKD) appear to have limited health literacy (HL), which is associated with lower self-care, according to a Singapore study.

Limited health literacy in CKD patients tied to poor self-care

22 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

BMI and glycaemic status significantly affect CV risk in patients treated with anthracyclines

BMI and glycaemic status significantly affect CV risk in patients treated with anthracyclines

Long-term data solidify partial-breast RT as standard of care in low-risk early breast cancer

Long-term data solidify partial-breast RT as standard of care in low-risk early breast cancer

Carvedilol trumps propranolol in preventing decompensation in cirrhosis

Carvedilol trumps propranolol in preventing decompensation in cirrhosis

Penpulimab extends survival in R/M nasopharyngeal carcinoma

Penpulimab extends survival in R/M nasopharyngeal carcinoma

Metabolic burden ups risk of death in CHB patients with SLD

Metabolic burden ups risk of death in CHB patients with SLD

IgAN drug hits target in phase III study

IgAN drug hits target in phase III study

Paternal mental distress may affect child development

Paternal mental distress may affect child development

Original New Drug Application Approvals by US FDA (16-31 May 2025)

Original New Drug Application Approvals by US FDA (16-31 May 2025)

Wearable electroencephalograph device useful for detecting absence seizures

Wearable electroencephalograph device useful for detecting absence seizures

Limited health literacy in CKD patients tied to poor self-care

Limited health literacy in CKD patients tied to poor self-care